- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04582643
Pilot Test of a Healthy Metabolic Behaviour Tool
November 18, 2021 updated by: KK Women's and Children's Hospital
Validation of a Healthy Metabolic Behavior Tool for Overweight and Obese Women
This study aims to validate and pilot test the short-term intervention effect of a newly developed healthy metabolic behaviour tool, named as the 6P tool, on dietary attitude/ practice and body weight changes over one month among overweight and obese women.
A total of 50 women, aged 21-40 years, BMI ≥25 kg/m2, who are attending the preconception clinic and planning for a pregnancy over the next one year, will be invited to participate in this pilot study.
The recruitment period is estimated to take up to 10 weeks, with subsequent 1 month follow-up visit.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Preconception is a stage that could critically influence subsequent antenatal and postnatal health of mother and offspring.
In Singapore, approximately one-third of women are overweight and obese during the preconception period.
In the present pilot study, the investigators aim to introduce a simple, self-administered tool that can identify discrete components of an individual's diet, which would lead to self-awareness, self-evaluation and self-education, and over time, results in a positive change in eating habits and health.
Specifically, the study aims i) to validate a newly developed tool that comprises six main dietary components (6P), namely Portion, Proportion, Pleasure, Phase, Physicality and Psychology in overweight and obese women during the preconception period; (ii) and to assess the short-term intervention effect of the 6P tool on dietary attitude/ practice and body weight changes over one month.
The investigators hypothesise that intervention using this 6P tool in overweight and obese women will help them to promote healthy eating behaviours and reduce body weight.
This study targets to recruit 50 overweight/ obese preconception women, from KK Women's and Children's Hospital, to evaluate the effectiveness of the tool over one month.
Throughout the one month follow up period, nudges in the form of text messages/images related to the 6P goals will be sent to participants through mobile phone.
This validated 6P tool is planned to be applied in a preconception targeted intervention cohort in order to build a positive mental model in healthy eating among overweight and obese women, enhancing awareness and belief towards weight management behaviour, and promoting a healthy life cycle.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore
- KK Women's and Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- age 21-40 years
- body mass index >= 25 kg/m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 6P intervention
6P assessment along with education provided based on the 6P components.
|
6P assessment targeting on diet, activity and mentality, along with education provided based on the 6P components.
The 6P tool serves the functions to help the women to self-monitor and be aware of their negative lifestyle choices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Meal portion size
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the portion size rating (scores1-7) in the 6P tool before and after the intervention.
Higher score indicates higher portion size.
|
Between baseline and follow-up visit (1 month)
|
Vegetable intake
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the proportion assessment for vegetable intake in the 6P tool before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Pleasure food intake
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the frequency of pleasure food intake in the 6P tool before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Meal timing
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the percentage of total caloric intake during the day and night in the 6P tool before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Physical activity
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the duration of physical activity in the 6P tool before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Motivational level
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the rating of motivational level (scores 1-9) in the 6P tool before and after the intervention.
Higher score indicates higher motivational level.
|
Between baseline and follow-up visit (1 month)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight changes
Time Frame: Between baseline and follow-up visit (1 month)
|
Weight changes in kg before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Body mass index changes
Time Frame: Between baseline and follow-up visit (1 month)
|
Body mass index changes in kg/m2 before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Dietary behavioral changes
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the Three Factor Eating Questionnaire before and after the intervention
|
Between baseline and follow-up visit (1 month)
|
Activity intensity changes
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the International Physical activity Questionnaire
|
Between baseline and follow-up visit (1 month)
|
Screen viewing time changes
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the Sedentary Behavioural Questionnaire
|
Between baseline and follow-up visit (1 month)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clarify, usefulness and acceptability of the 6P tool
Time Frame: Follow up visit at 1 month
|
Assessed by the feedback evaluation questionnaire
|
Follow up visit at 1 month
|
Usefulness and acceptability for the nudges
Time Frame: 1 month
|
Assessed by the nudges rating scale and feedback evaluation questionnaire
|
1 month
|
Other lifestyle changes
Time Frame: Between baseline and follow-up visit (1 month)
|
Assessed by the general lifestyle questionnaire
|
Between baseline and follow-up visit (1 month)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jerry Kok Yen Chan, PhD, KK Women's and Children's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Actual)
September 30, 2021
Study Completion (Actual)
September 30, 2021
Study Registration Dates
First Submitted
September 25, 2020
First Submitted That Met QC Criteria
October 5, 2020
First Posted (Actual)
October 9, 2020
Study Record Updates
Last Update Posted (Actual)
November 19, 2021
Last Update Submitted That Met QC Criteria
November 18, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIRB 2020/2530
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obese
-
Zagazig UniversityCompletedAbdominal Surgery | Obese PatientsEgypt
-
University Hospital, GhentCompleted
-
Bristol-Myers SquibbCompletedObese But Otherwise Healthy ParticipantsUnited States
-
University Hospital, Clermont-FerrandUnknownObese Adolescent | Elite Adolescent AthletesFrance
-
Beth Israel Deaconess Medical CenterCompletedObese | Lean | Obese DiabeticsUnited States
-
Sabrin Mohamed Taha AbdelwahabCompletedObese Women With PCOSEgypt
-
University Hospital, Clermont-FerrandUnknown
-
Eisai Inc.CompletedPharmacokinetics in Obese AdolescentsUnited States
-
Glostrup University Hospital, CopenhagenCompletedMorbidly Obese | Intubationtime | IntubationattemptsDenmark
Clinical Trials on 6P intervention
-
National Institute of Allergy and Infectious Diseases...Johns Hopkins Bloomberg School of Public Health; National Institutes of Health...RecruitingSARS-CoV-2 InfectionUnited States
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedColorectal Carcinoma | Healthy Subject | Health Status UnknownUnited States
-
University of FloridaCompletedSensitivityUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health and...RecruitingHuman Papillomavirus InfectionUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy
-
Nottingham Trent UniversityUnknownOverweight and ObesityUnited Kingdom
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...American Cancer Society, Inc.Completed